|Bid||32.860 x 4900|
|Ask||32.870 x 1400|
|Day's Range||32.840 - 33.150|
|52 Week Range||29.830 - 37.390|
|PE Ratio (TTM)||27.67|
|Dividend & Yield||1.28 (3.87%)|
|1y Target Est||N/A|
No analyst has recommended any form of "sell" for Pfizer stock.
Pfizer Inc. (PFE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
In 2016, Pfizer’s (PFE) Lipitor reported revenues of ~$1.8 billion, which represented a ~5% YoY (year-over-year) fall.